Repurposing some older drugs that cross the blood-brainier and have potential anticancer activity to provide new treatment options for glioblastoma
- Creator: Rundle-Thiele, Dayle , Head, Richard , Cosgrove, Leah , Martin, Jennifer H.
- Resource Type: journal article
- Date: 2016
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19
- Creator: Martin, Jennifer H. , Head, Richard
- Resource Type: journal article
- Date: 2021
The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment
- Creator: Lumbers, Eugenie R. , Head, Richard , Smith, Gary R. , Delforce, Sarah J. , Jarrott, Bevyn , Martin, Jennifer H. , Pringle, Kirsty G.
- Resource Type: journal article
- Date: 2022
“LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy
- Creator: Jarrott, Bevyn , Head, Richard , Pringle, Kirsty G. , Lumbers, Eugenie R. , Martin, Jennifer H.
- Resource Type: journal article
- Date: 2022
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target
- Creator: Islam, Saiful , Wang, Shudong , Bowden, Nikola , Martin, Jennifer , Head, Richard
- Resource Type: journal article
- Date: 2021
The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells
- Creator: Hosein, Abdel Nasser , Lim, Yi Chieh , Day, Bryan , Stringer, Brett , Rose, Stephen , Head, Richard , Cosgrove, Leah , Sminia, Peter , Fay, Michael , Martin, Jennifer H.
- Resource Type: journal article
- Date: 2015
Where is the radiobiology and pharmacology research to improve outcomes in glioblastoma?
- Creator: Fay, Michael , Head, Richard , Martin, Jennifer
- Resource Type: journal article
- Date: 2015